EGFR and neoplasm: Based on the observed tumor cellularity, we would expect clonal EGFR mutations to present an allelic frequency of at least 0.31 on average (average cellularity divided by half), even in the absence of copy number gains, which are common in NSCLC and increase the observed allelic frequency.